Quarterly report pursuant to Section 13 or 15(d)

Supplemental Cash Flow Information Disclosure: Schedule of Cash Flow, Supplemental Disclosures (Tables)

v2.4.0.8
Supplemental Cash Flow Information Disclosure: Schedule of Cash Flow, Supplemental Disclosures (Tables)
3 Months Ended
Sep. 30, 2014
Tables/Schedules  
Schedule of Cash Flow, Supplemental Disclosures

 

 

 

Nine Months Ended

September 30,

 

 

2014

 

2013

Cash paid for interest

 

$

229,571

 

$

95,042

Cash paid for income taxes

 

$

-

 

$

100

Series C Dividend payable in current liabilities

 

$

-

 

$

27,068

Series D Dividend payable in current liabilities

 

$

53,054

 

$

24,407

 

 

 

 

 

 

 

Non-Cash investing and financing transactions

 

 

 

 

 

 

Repayment of senior secured notes payable with issuance of Series D preferred shares

 

$

-

 

$

749,982

Financing the purchase of equipment under a 4 year loan agreement

 

$

49,204

 

$

83,507

Beneficial conversion feature on warrants issued in conjunction with Series D preferred shares

 

$

24,279

 

$

-

Shares issued in acquisition of Dr. Pave

 

$

175,000

 

$

-

Deemed dividend related to warrant extension

 

$

26,832

 

$

-